Antipsychotic treatment in clinical high risk for psychosis: Protective, iatrogenic or further risk flag?

被引：12
|
作者：
Raballo, Andrea [1 ,2 ]
Poletti, Michele [3 ]
Preti, Antonio [4 ]
机构：
[1] Univ Perugia, Dept Med, Sect Psychiat Clin Psychol & Rehabil, Piazzale Lucio Severi 1, I-06132 Perugia, Italy
[2] Perugia Univ Hosp, Ctr Translat Phenomenol & Dev Psychopathol, Perugia, Italy
[3] Azienda Unita Sanit Locale IRCCS Reggio Emilia, Child & Adolescent Neuropsychiat Serv, Dept Mental Hlth & Pathol Addict, Reggio Emilia, Italy
[4] Univ Turin, Dept Neurosci, Turin, Italy
来源：
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY | 2021年 / 55卷 / 05期
关键词：
D O I：
10.1177/0004867420984836
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：442 / 444
页数：3
相关论文
共 50 条
  • [1] Antipsychotic Treatment in People at Clinical High Risk for Psychosis
    Di Lisi, Alessandro
    Pupo, Simona
    Menchetti, Marco
    Pelizza, Lorenzo
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2024, 44 (05) : 502 - 508
  • [2] Antipsychotic treatment in clinical high risk for psychosis: Iatrogenesis related to dopamine supersensitivity psychosis?
    Bastiampillai, Tarun
    Chan, Sherry Kit Wa
    Allison, Stephen
    Copolov, David
    Looi, Jeffrey C. L.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2022, 56 (01): : 97 - 97
  • [3] Baseline Antipsychotic Dose and Transition to Psychosis in Individuals at Clinical High Risk
    Raballo, Andrea
    Poletti, Michele
    Preti, Antonio
    JAMA PSYCHIATRY, 2024, 81 (07) : 727 - 730
  • [4] Individualized risk components guiding antipsychotic delivery in patients with a clinical high risk of psychosis: application of a risk calculator
    Zhang, TianHong
    Xu, LiHua
    Li, HuiJun
    Cui, HuiRu
    Tang, YingYing
    Wei, YanYan
    Tang, XiaoChen
    Hu, YeGang
    Hui, Li
    Li, ChunBo
    Niznikiewicz, Margaret A.
    Shenton, Martha E.
    Keshavan, Matcheri S.
    Stone, William S.
    Wang, JiJun
    PSYCHOLOGICAL MEDICINE, 2022, 52 (15) : 3412 - 3421
  • [5] Cognitive changes following antidepressant or antipsychotic treatment in adolescents at clinical risk for psychosis
    Bowie, Christopher R.
    McLaughlin, Danielle
    Carrion, Ricardo E.
    Auther, Andrea M.
    Cornblatt, Barbara A.
    SCHIZOPHRENIA RESEARCH, 2012, 137 (1-3) : 110 - 117
  • [6] Antipsychotic medication in individuals at Clinical High Risk for Psychosis: what recommendations for clinicians?
    Di Lisi, Alessandro
    Pelizza, Lorenzo
    JOURNAL OF PSYCHOPATHOLOGY, 2023, 29 (3-4): : 110 - 116
  • [7] Treatment possibilities for individuals at clinical high risk of psychosis
    Brummitt, Kali
    Addington, Jean
    EARLY INTERVENTION IN PSYCHIATRY, 2013, 7 (02) : 155 - 161
  • [8] The impact of psychosis and antipsychotic treatment on cardiovascular risk factors
    Dehelean, L.
    Draghici, A.
    Manea, M.
    Papava, I.
    Manea, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S554 - S555
  • [9] Protective factors in Chinese university students at clinical high risk for psychosis
    Shi, Jingyu
    Wang, Lu
    Yao, Yuhong
    Chen, Fazhan
    Su, Na
    Zhao, Xudong
    Zhan, Chenyu
    PSYCHIATRY RESEARCH, 2016, 239 : 239 - 244
  • [10] The relation of atypical antipsychotic use and stress with weight in individuals at clinical high risk for psychosis
    Hampton, Joya N.
    Trotman, Hanan D.
    Addington, Jean
    Bearden, Carrie E.
    Cadenhead, Kristin S.
    Cannon, Tyrone D.
    Cornblatt, Barbara A.
    Mathalon, Daniel H.
    McGlashan, Thomas H.
    Tsuang, Ming T.
    Perkins, Diana O.
    Seidman, Larry J.
    Woods, Scott W.
    Walker, Elaine F.
    STRESS AND HEALTH, 2018, 34 (05) : 591 - 600
12345